Magnesium Sulfate in the Management of Patients with Fisher Grade 3 Subarachnoid Hemorrhage: A Pilot Study
- 1 September 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 47 (3) , 602-607
- https://doi.org/10.1097/00006123-200009000-00014
Abstract
OBJECTIVE: To evaluate the effect of magnesium sulfate (MgSO4) on the clinical course of patients with severe aneurysmal subarachnoid hemorrhage (SAH). METHODS: Ten patients with Fisher Grade 3 aneurysmal SAH were evaluated. The patients were given a bolus as well as a constant infusion of intravenous MgSO4 up to 10 days postictus. Blood magnesium levels were obtained to adjust the daily requirement of MgSO4. The goal was to raise the serum level to 2.0 to 2.5 mmol/L or twice the baseline serum level. Daily transcranial Doppler (TCD) ultrasonography was performed on each patient, insonating both anterior cerebral and middle cerebral arteries. Further management followed standard protocols, including the use of nimodipine and hypervolemic therapy. TCD ultrasonographic findings, as well as clinical evidence of cerebral vasospasm, were documented. All patients had a 3-month assessment using the Glasgow Outcome Scale. RESULTS: After administration of a 20 mmol MgSO4 bolus infusion and an average daily continuous infusion of 84.7 mmol, 8 of 10 patients achieved the predetermined serum magnesium levels. No adverse affects were noted during the infusions. Five patients exhibited evidence of vasospasm on TCD ultrasonography; vasospasm was severe in two patients (velocities, >200 cm/s). Three patients, including the two patients in whom TCD ultrasonography demonstrated severe vasospasm, exhibited clinical evidence of vasospasm. Two patients had a Glasgow Outcome Scale score of 3; the remainder had Glasgow Outcome Scale scores of 5. CONCLUSION: Administration guidelines for the use of MgSO4 in aneurysmal SAH were established. A prospective double-blind placebo-controlled trial is required to establish the effectiveness of MgSO4 for treating vasospasm in aneurysmal SAH.Keywords
This publication has 23 references indexed in Scilit:
- Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1998
- A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North AmericaJournal of Neurosurgery, 1997
- The Safety and Efficacy of Cyclosporine A in the Prevention of Vasospasm in Patients with Fisher Grade 3 Subarachnoid Hemorrhages: A Pilot StudyNeurosurgery, 1997
- Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcomeJournal of Neurosurgery, 1996
- Improved outcome after rupture of anterior circulation aneurysms: a retrospective 10-year review of 224 good-grade patientsJournal of Neurosurgery, 1995
- The International Cooperative Study on the Timing of Aneurysm Surgery. The North American experience.Stroke, 1992
- Therapeutic Use of Magnesium Sulfate in Selected Cases of Cerebral Ischemia and SeizureNew England Journal of Medicine, 1988
- Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid HemorrhageNew England Journal of Medicine, 1983
- Relation of Cerebral Vasospasm to Subarachnoid Hemorrhage Visualized by Computerized Tomographic ScanningNeurosurgery, 1980
- ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE: A Practical ScalePublished by Elsevier ,1975